Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
768.52-
QQQ
716.240.03%
BTC/USD
78732.001.3438%
DIA
534.310.14%
GLD
406.780.52%
TLT
82.960.1%

SpyGlass Pharma Inc

SGPNASDAQ
Trade with Public
Trade with Public
$26.42
-0.51-1.89%
At close: Aug 27, 5:00 PM EST
$26.42
-0.51-1.89%
Pre-Market: 4:43 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

SpyGlass Pharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for SpyGlass Pharma (SGP).

Price Target Range — 2 Quarters

Analyst Consensus — 6 Analysts

6Buy
Consensus RatingBuy# Analysts6Avg. Consensus PT$44Upside to Avg. PT+66.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 14, 2026Raymond JamesChristopher RaymondInitiateOutperform$39
Mar 10, 2026HC Wainwright & Co.Yi ChenInitiateBuy$37
More with Benzinga EdgeGet Access

Analyst Ratings News

This Aehr Test Systems Analyst Begins Coverage On A Bearish Note; Here Are Top 4 Initiations For Friday

Wall Street analysts changed ratings for top names. Visit our analyst ratings page for details. SGP initiated with Outperform, $39 PT.
Avi Kapoor

PRO
Raymond James Initiates Coverage On SpyGlass Pharma with Outperform Rating, Announces Price Target of $39

Raymond James analyst Christopher Raymond initiates coverage on SpyGlass Pharma (NASDAQ:SGP) with a Outperform rating and announces Price Target of $39.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Initiates Coverage On SpyGlass Pharma with Buy Rating, Announces Price Target of $37

HC Wainwright & Co. analyst Yi Chen initiates coverage on SpyGlass Pharma (NASDAQ:SGP) with a Buy rating and announces Price Target of $37.
Benzinga Newsdesk

This MongoDB Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Wall Street analysts changed ratings on top companies. See full list at benzinga.com/analyst-stock-ratings. MDB outlook downgraded to Neutral.
Avi Kapoor

PRO
Citigroup Initiates Coverage On SpyGlass Pharma with Buy Rating, Announces Price Target of $42

Citigroup analyst Yigal Nochomovitz initiates coverage on SpyGlass Pharma (NASDAQ:SGP) with a Buy rating and announces Price Target of $42.
Benzinga Newsdesk

PRO
Leerink Partners Initiates Coverage On SpyGlass Pharma with Outperform Rating, Announces Price Target of $42

Leerink Partners analyst Marc Goodman initiates coverage on SpyGlass Pharma (NASDAQ:SGP) with a Outperform rating and announces Price Target of $42.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved